Analysis of Errors Identified during Regulatory Review of Risk Management Plans Submitted as Part of Registration Dossiers
Scientific relevance. On 6 December 2022, an updated version of the Rules for Good Pharmacovigilance Practice of the Eurasian Economic Union (EAEU GVP) came into force. The greatest changes were made to the requirements for pharmacovigilance documents, particularly the risk management plan (RMP). In...
Main Authors: | A. O. Lovkova, S. M. Gyulakhmedova, A. A. Druzhinina, A. A. Nekipelova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2023-12-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/390 |
Similar Items
-
Risk Management Plan: An Expert Analysis of Changes to the EAEU Good Pharmacovigilance Practice Requirements for the Content and Submission of the Document
by: T. M. Bukatina, et al.
Published: (2023-03-01) -
Analysis of Noncompliances with Legislative Requirements in Pharmacovigilance Materials of Registration Dossiers
by: E. O. Zhuravleva, et al.
Published: (2021-12-01) -
Changes to the EAEU Guideline on Good Pharmacovigilance Practices
by: B. K. Romanov
Published: (2023-03-01) -
Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier
by: I. I. Snegireva, et al.
Published: (2020-12-01) -
Pharmacovigilance System Master File: An Overview of Changes in the EAEU Good Pharmacovigilance Practice
by: N. Yu. Velts, et al.
Published: (2023-03-01)